INUV · NYSE American
Average $4.21 (+923.0% upside)
The latest rating actions, newest first
| Firm | Date | Action | Rating |
|---|---|---|---|
| Ladenburg Thalmann | Jul 8, 2026 | Maintains | Buy |
| HC Wainwright & Co. | Mar 9, 2026 | Maintains | Buy |
| Freedom Broker | Feb 10, 2026 | Initiates | Buy |
| HC Wainwright & Co. | Jan 29, 2026 | Maintains | Buy |
| HC Wainwright & Co. | Nov 10, 2025 | Maintains | Buy |
Updated Apr 28, 2026
Inuvo is experiencing slow growth in revenue and lower gross margins due in part to pressure from new customer campaigns. However, they have been able to decrease operating expenses, resulting in an adjusted EBITDA loss that was lower than expected. With potential for revenue growth in the future, the company should be able to increase their gross margins to over 80%, leading to improved financial performance.
Inuvo is currently facing numerous challenges including dilution risk from potential capital raises, high levels of competition, execution and technology risks, customer concentration, and key personnel risks. These challenges, combined with the recent revenue miss and change in executive team, have led to a negative outlook on the stock. Despite potential long-term opportunities with its technology, the company will likely face near-term struggles as it transitions to a high-margin technology-first platform and tries to recover from lower than expected 4Q25 revenue. This has resulted in a lowered price target of $6, below its current trading level of $2.47, reflecting a 1.2x EV/revenue multiple on the 2026 revenue forecast of $72.0M.
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.
